#1372 Improved CSPCa Detection Rate by MRI-TRUS Fusion Biopsy Compared to Conventional Biopsy: A Large Single-Center Experience

#1114 Prostate Cancer Management Across Asia and Oceania: Insights from a Multi-Country UAA Survey

#1117 Gleason 6 cancer - time for a rebrand?

#1151 Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer Patients: A Prospective Study

#1166 Diagnostic efficacy of 68Ga-PSMA-PET/CT scan as a single staging modality in prostate cancer: Evidence from a tertiary healthcare centre

#1168 Prostate Cancer: A Novel MRI-Based Predictive Model Co-Registered with Whole-Mount Pathology

#1186 Analysis of Time to Prostate-specific antigen (PSA) Nadir After Radical Prostatectomy In Taiwan

#1233 Comparison of Ga68 PSMA-PET/MRI Fusion Based Cognitive-Targeted versus MRI-TRUS Fusion Biopsy for the Diagnosis of Prostate Cancer- A Pilot Study

#1278 PREDICTIVE FACTORS OF PATHOLOGICAL UPGRADING IN INDIAN PATIENTS WITH GLEASON SCORE 3+4 PROSTATE CANCER: WHEN TO OFFER ACTIVE SURVEILLANCE?

#1290 Targeted Versus Targeted Plus Random Transperineal MR/US Prostate Biopsy in patients with a single lesion on MRI: Is There Added Value?

#1322 Deintensification of androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer: an exploratory study of survival outcomes and predictive factors

#1338 Transperineal Prostate Biopsy Using Freehand Technique Under Local Anaesthetic: A Systematic Review and Meta-analysis

#740 Autologous Dendritic Cell Vaccination as Add-On Therapy Improves Overall Survival in Stage IV Prostate Cancer: A Retrospective Matched Cohort Study

#786 PSMA-Targeted Self-Assembled DNA Tetrahedral Nanoprobes for In Vivo Imaging: A Novel Strategy for Non-Invasive Diagnosis and Metastasis Monitoring in Prostate Cancer

#851 SPP1+ Macrophage/FAP+ Fibroblast Crosstalk Predicts Disease Progression and Immunosuppressive Niche in Prostate Cancer